COVID in California: Booster shot for children ages 5-11 could be approved this week

COVID in California: Booster shot for children ages 5-11 could be approved this week
Written by admin_3fxxacau

San Francisco is in a new pandemic location: It no longer has lower rates of COVID-19 cases than the entire country, a reversal of its status throughout the pandemic. Legislation to encourage more people to get vaccinated against COVID-19 appears to have fallen in vogue among California lawmakers. Masks, on the other hand, are being highly recommended by health workers from across the Bay Area as coronavirus infections continue to climb.

As new infections rise, USPS offers another round of free coronavirus tests

Residential households in the United States are now eligible for another order of free home tests on Each order now includes eight rapid antigenic coronavirus tests, which are supposed to arrive in two separate packages with four tests in each package. Each package will be shipped free of charge with its own tracking number.

A booster shot for children aged 5 to 11 could be approved this week

The Food and Drug Administration is expected to authorize a booster shot of the Pfizer-BioNTech vaccine for children ages 5 to 11 as early as Tuesday, according to several people familiar with the plan who spoke to the New York Times. An advisory committee of vaccine experts is scheduled to meet with officials from the U.S. Centers for Disease Control and Prevention on Thursday, according to the report. This will likely be followed by an independent recommendation from Dr. Rochelle P. Walensky, director of the agency. In a clinical trial conducted by Pfizer, an additional vaccine dose of the Pfizer vaccine for ages 5 to 11 showed a six-fold increase in antibody levels against the wild strain of coronavirus one month after receiving the booster, compared to one month. after receiving a second dose. They would become the youngest age group eligible for booster doses.

FDA approves first at-home test to detect coronavirus, influenza and RSV

The US Food and Drug Administration on Monday authorized the first non-prescription multi-analyte coronavirus test kit. The Labcorp Seasonal Respiratory Virus RT-PCR DTC test, available without a prescription, allows a person to collect a nasal swab sample themselves at home to identify and differentiate multiple respiratory viruses at the same time, detecting influenza A and B, commonly known as influenza, respiratory syncytial virus, commonly known as RSV, as well as SARS-CoV-2, the virus that causes COVID-19. Sample results, which must be submitted to Labcorp for testing, are delivered through an online portal, with follow-up by a healthcare provider for positive or invalid test results. “While the FDA has now authorized many COVID-19 tests without a prescription, this is the first authorized test for influenza and RSV, along with COVID-19, where an individual can self-identify their need for a test, order it, collect their sample, and send it to the lab for analysis, without seeing a medical professional,” said Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health. “Rapid progress made in consumer access to diagnostic testing, including the ability to collect your sample at home for influenza and RSV without a prescription, brings us one step closer to testing for these viruses that could be done entirely at home.”

Childhood COVID cases soar amid national BA.2 surge

Reported cases of COVID-19 in children numbered 93,511 in the United States last week, compared to 62,467 cases recorded the previous week. Children accounted for more than 18% of cases nationally, according to data released on Monday by the American Academy of Pediatrics and the Association of Children’s Hospitals. Nationwide, cases have increased by about 60% in the past two weeks after public health officials lifted most virus mitigation measures as the highly infectious omicron subvariant BA .2 and its BA.2.12.1 subline became dominant. Pediatric COVID cases fell to their lowest point this year in the first week of April, with 25,915 reported cases, but have risen more than 260% since then.

BA.4 and BA.5 sublines elevated to ‘variants of concern’ by European CDC

The omicron coronavirus variant BA.4 and BA.5 sublines have been reclassified from variants of interest to variants of concern by the European Center for Disease Prevention and Control, as public health experts fear they cause a new wave of cases around the world. continent. “Preliminary studies suggest a significant change in the antigenic properties of BA.4 and BA.5 compared to BA.1 and BA.2, in particular compared to BA.1,” the agency said. wrote in his newsletter. He added that the variants show signs of immunity evasion, meaning even people previously infected with omicron are susceptible to re-infection. “The growth advantage currently observed for BA.4 and BA.5 is likely due to their ability to evade immune protection induced by prior infection and/or vaccination, particularly if this has diminished over time,” the agency said.

SF schools report highest number of COVID cases since winter omicron surge

San Fransisco Public School students and staff reported 320 cases of COVID-19 last week, including 303 exposure cases where infected people were at a school site within 48 hours of showing symptoms or testing positive for the coronavirus. This is the highest figure since late January, at the end of omicron’s winter surge. It also marks a 15% increase in cases in schools compared to the previous week. Campus infections have been on the rise since the San Francisco Unified School District lifted its mask mandate a month ago. They also reflect a substantial increase in community spread, with San Francisco reporting one of the highest case rates in the nation. The city one positive coronavirus test rate hit 11% on Monday – more than twice California Overall Rate 4.4%

Coachella and Stagecoach festivals lead to increase in COVID cases and hospitalizations

Following the Coachella Valley Music and Arts and Stagecoach country music festivals, which took place over three consecutive weekends in April, Riverside County is reporting a substantial increase in coronavirus infections. COVID-19 cases have risen 736% in the area around the Empire Polo Club in Indio, the venue where the festivals were held, since May 1, according to the desert sun. Hospitalizations are also on the rise, according to the report. There were 62 patients hospitalized with COVID-19 in the region on Friday, up 12 from Tuesday. Health officials are urging residents to resume indoor masking and keep up to date with their vaccinations during the current wave. “As increases are seen in many parts of the country as well as across the county, these increases can be attributed to waning immunity, the spread of more contagious variants, and potentially reduced use of mitigation measures, such as masking,” the Riverside County deputy said. Public health officer Dr. Jennifer Chevinsky said.

Fauci says once was enough

White House chief medical adviser Dr. Anthony Fauci said Sunday that if Donald Trump ran for president again and won, he would not stay. On Sunday, when asked by CNN’s Jim Acosta if he would stay on if Trump returned, Fauci laughed and said, “Well, no.” When asked if he would have confidence that Trump could deal with the pandemic, Faudi replied: “If you look at the history of the response during the administration, I think, you know, at best you can say it was not optimal.” He added: “History will speak for itself on this.” Trump has not announced whether he will reapply for the job.

Pfizer vaccine fades against omicron within weeks of doses 2 and 3

Immunity to omicron variant coronavirus wanes weeks after receiving second and third doses of Pfizer, according to a study published Friday in JAMA Network Open. Danish scientists found that antibody levels declined rapidly after the vaccination series ended and were less protective than they were with earlier wild, alpha and delta coronavirus variants. Compared to the latter, protection against omicron fell by 76% four weeks after the second injection and fell to 19% at 12 to 14 weeks. The authors said additional boosting might be needed, especially for the elderly, but “retained T-cell immunity and non-neutralizing antibodies may still provide protection against hospitalization and death.”

The death toll in the United States is just under a million for the total of the pandemic

Tracking by researchers at Johns Hopkins University on Sunday showed the United States has come within 400 deaths of the tragic reality that one million Americans have lost their lives to COVID-19. The nationwide death toll was 999,602 as of Sunday evening. The Johns Hopkins Project has been a widely used and respected tool since the pandemic began. President Biden on Thursday ordered flags to be lowered at half mast to honor Americans who have died of COVID-19 as the death toll nears one million.

#COVID #California #Booster #shot #children #ages #approved #week

About the author


Leave a Comment